Page last updated: 2024-09-04

16-fluoro-5-androsten-17-one and Body Weight

16-fluoro-5-androsten-17-one has been researched along with Body Weight in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haines, DC; Hursting, SD; James, SJ; Miller, BJ; Perkins, SN; Phang, JM1
Hursting, SD; Mei, JJ; Perkins, SN; Phang, JM1
Lewbart, ML; Pashko, LL; Schwartz, AG1

Other Studies

3 other study(ies) available for 16-fluoro-5-androsten-17-one and Body Weight

ArticleYear
Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.
    Carcinogenesis, 1997, Volume: 18, Issue:5

    Topics: Androstenes; Animals; Antineoplastic Agents; Body Weight; Dehydroepiandrosterone; Genes, p53; Liver; Longevity; Male; Mice; Mice, Knockout; Nucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis

1997
p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages.
    Cancer letters, 1998, Jul-17, Volume: 129, Issue:2

    Topics: Androstenes; Animals; Blotting, Western; Body Weight; Cells, Cultured; Dehydroepiandrosterone; Down-Regulation; Energy Intake; Genes, p53; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II

1998
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides.
    Carcinogenesis, 1991, Volume: 12, Issue:11

    Topics: Androstenes; Animals; Body Weight; Deoxyribonucleosides; Drug Interactions; Female; Mice; Mice, Inbred Strains; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate

1991